Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome

NCT01541891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: PRO-148 Ophthalmic Solution
DRUG: Active Comparator: SYSTANE ® Ophthalmic Solution

Sponsor

Laboratorios Sophia S.A de C.V.